Safety and Efficacy of Skin Cleanser Contained Roselle Extract in Acne
NCT ID: NCT00701480
Last Updated: 2008-06-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2
50 participants
INTERVENTIONAL
2008-04-30
2008-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Traditional medicine with longstanding used of herbal ingredients for skin problems and beauty is increasing more popular. Hibiscus sabdariffa L.(Roselle) is used as food, drink and topical formulation for skin infection in Thai traditional medicine. The extract from calyces contained polyphenolic compounds and anthocyanins that showed antioxidant and keratolytic activities. There for skin cleanser with Roselle extract might be benefit to acne by loosen comedone, reduce Propionibacterium acne and prevent keratinocyte injury.
The purposes of this study is to evaluate skin cleanser contained Roselle extract in two aspects ; 1. safety for irritation and allergic effects, 2. efficacy in acne as cleanser alone and as supportive care with others acne therapies.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
skin cleanser contained Hibiscus sabdariffa
skin cleanser contained Hibiscus sabdariffa extract
face washing 2-3 times/day
2
marketed skin cleanser
marketed skin cleanser
face washing 2-3 times/day
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
skin cleanser contained Hibiscus sabdariffa extract
face washing 2-3 times/day
marketed skin cleanser
face washing 2-3 times/day
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* clinical diagnosis of mild to moderately severe acne vulgaris(grade 1-3)
* have at least 10 facial acne lesions
* not changing any acne treatment during study period
* able to follow up according to protocol
* Written informed consent
Exclusion Criteria
* severe acne(grade4 or nodulocystic acne)
* treated with isotretinoin orally during the last 3 months
* have other systemic disease or illness
* have allergic history to Roselle
12 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Research Council of Thailand
OTHER_GOV
Thammasat University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Thammasat University
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mali - Achariyakul, MD.
Role: PRINCIPAL_INVESTIGATOR
Thammasat University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Thammasat University
KlongLaung, Pathumtanee, Thailand
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Mali - Achariyakul, MD.
Role: primary
Narumon Teeranurak, MD.
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MTU-E-1-002/51
Identifier Type: -
Identifier Source: org_study_id